Oxford Medical Simulation secures 5M growth financing

"OMS builds virtual reality simulation software for the healthcare sector, giving nurses, doctors, and allied health professionals a way to practise clinical scenarios, emergencies, difficult conversations, procedures, anytime and anywhere, without putting real patients at risk. The platform runs on both VR headsets and standard screens, and pairs immersive scenarios with evidence-based feedback and performance analytics that let institutions track readiness across their entire workforce."

"This financing allows us to invest confidently in the next phase of OMS. Our partners in US healthcare and academia are focused on outcomes, safer practice, better-prepared staff and more efficient delivery. This growth capital from Salica means we can move faster on exactly those priorities: expanding our breadth and depth of content, deepening our analytics capabilities, and supporting more institutions to transform their training."

"Founded in 2017 by clinicians, the company now works with hospitals, health systems, and universities across the US, UK, and internationally. It currently delivers upwards of 35,000 simulations per month, and in its Series A announcement in January 2024 cited a 74% reduction in staffing and equipment costs compared to traditional physical simulation methods."

Oxford Medical Simulation, a London-based healthtech company, secured £5 million in growth financing from Salica Investments to accelerate its US expansion and advance AI-driven product development. The company provides virtual reality simulation software enabling nurses, doctors, and allied health professionals to practice clinical scenarios, emergencies, difficult conversations, and procedures without patient risk. The platform operates on VR headsets and standard screens, offering immersive scenarios paired with evidence-based feedback and performance analytics. Founded in 2017 by clinicians, OMS currently delivers over 35,000 simulations monthly across US, UK, and international institutions. The company demonstrated 74% cost reduction compared to traditional physical simulation methods, with funding supporting content expansion, analytics enhancement, and institutional transformation.

Read at TNW | Health-Tech